Pramel13os, an enigmatic non-coding RNA located on the opposite strand of PRAME-like 13, presents a complex puzzle in our understanding of its biological function. Despite extensive research, its specific role remains elusive, adding to the intricacies of non-coding RNA biology. While the protein-coding PRAME-like 13 on the opposite strand suggests potential cis-regulation, Pramel13os's precise molecular functions and interactions are not well-defined. Its sequence characteristics, devoid of a protein-coding potential, hint at possible roles in transcriptional regulation, chromatin organization, or participation in intricate cellular networks. The lack of a known function underscores the challenges in deciphering the roles of non-coding RNAs, emphasizing the need for further exploration to unravel the intricacies of Pramel13os in cellular processes.
In terms of inhibition, a diverse set of chemicals targeting various cellular pathways reveals the complexity of regulating Pramel13os expression. These inhibitors act through distinct mechanisms, such as epigenetic modifications, interference with specific signaling cascades, and induction of DNA damage, reflecting the multifaceted regulatory landscape surrounding Pramel13os. The involvement of histone deacetylase inhibitors, DNA methyltransferase inhibitors, and bromodomain-containing protein inhibitors highlights the potential impact of epigenetic modifications on Pramel13os transcription. Additionally, inhibitors targeting signaling pathways, including TGF-β/Smad, PI3K/AKT, and MAPK/ERK, suggest a role for Pramel13os in these cellular cascades. The complexity of its regulatory network, as indicated by a wide array of inhibitors, implies a versatile and dynamic involvement in cellular homeostasis, which demands further investigation to unveil the intricate mechanisms governing Pramel13os function and regulation.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
Tyrphostin B42 inhibits Pramel13os through JAK/STAT signaling pathway blockade. By targeting JAK2, it disrupts downstream signaling, influencing the transcriptional activity of Pramel13os. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid inhibits Pramel13os through histone deacetylase (HDAC) inhibition. By preventing histone deacetylation, it maintains a condensed chromatin structure, limiting transcription of Pramel13os. | ||||||